Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach.

Oncology research and treatment - 1 Jan 2016

Schöffski Patrick, Wozniak Agnieszka, Schöffski Oliver, van Eycken Liesbet, Debiec-Rychter Maria

Abstract excerpt

BACKGROUND: Genetic analysis of tissue derived from patients with advanced gastrointestinal stromal tumors (GISTs) is not uniformly applied on a national and international level, even though mutational data can provide clinically relevant prognostic and predictive information, especially in patients qualifying for treatment with expensive targeted agents. METHODS: The current article describes the rationale for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Belgium
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Neoplasms

Share to Gastrointestinal Stromal Tumors

Share to Genetic Markers

Share to Genetic Testing

Share to Health Care Costs

Share to Neoplasm Proteins

Source

Identifiers

PMID: 27889785
DOI: 10.1159/000453057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach.PMID 27889785Read ↗

Pharmacogenetics in the treatment of gastrointestinal stromal tumors - an updated review.Semantic proximity Read ↗

Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice.Semantic proximity Read ↗

Micro-costing Diagnostics in Oncology: From Single-Gene Testing to Whole Genome SequencingSemantic proximity Read ↗

Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes.Semantic proximity Read ↗

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.Semantic proximity Read ↗

Practical aspects of risk assessment in gastrointestinal stromal tumors.Semantic proximity Read ↗

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.Semantic proximity Read ↗

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors.Semantic proximity Read ↗

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance.Semantic proximity Read ↗

Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based study.Semantic proximity Read ↗

Clinical and economic aspects of KRAS mutational status as predictor for epidermal growth factor receptor inhibitor therapy in metastatic colorectal cancer patients.Semantic proximity Read ↗

Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.